Abstract
From the “does the left hand know what the right hand is doing?” department: The Office of National Drug Control Policy this year issued a treatment plan calling for mobile vans to dispense buprenorphine and Vivitrol, but not methadone (see “ONDCP issues first ‘treatment plan: Not part of strategy,’” ADAW, Feb. 10; https://onlinelibrary.wiley.com/doi/10.1002/adaw.32619). But at the end of February, the Drug Enforcement Administration (DEA) proposed in no uncertain terms the need for mobile methadone (see story, p. 1). The DEA's long‐awaited move will go a long way to increasing access to treatment for opioid use disorder, reducing overdoses and improving health, according to the DEA itself.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
